Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma

Journal of the Medical Association of Thailand

Volumn 85, Issue 11, 2002, Pages 1156-1163

  Numbenjapon, Tontanai ^a   Mongkonsritragoon, Wichean ^a   Prayoonwiwat, Wichai ^a   Sriswasdi, Chantrapa ^a   Leelasiri, Apichai ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

Chemotherapy; Dexamethasone; Granisetron; Metoclopramide; Nausea; Vomiting

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; GRANISETRON; METOCLOPRAMIDE; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOPROPHYLAXIS; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HUMAN; LOW DRUG DOSE; MALE; NAUSEA AND VOMITING; NONHODGKIN LYMPHOMA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; XEROSTOMIA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHI-SQUARE DISTRIBUTION; CROSS-OVER STUDIES; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DOXORUBICIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRANISETRON; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; METOCLOPRAMIDE; MIDDLE AGED; NAUSEA; PATIENT SATISFACTION; PREDNISONE; PROBABILITY; TREATMENT OUTCOME; VINCRISTINE; VOMITING;

EID: 0036881832     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jenns K. Importance of nausea. Cancer Nurs 1994; 17: 488-93.
2. Moran C, Smith DC, Anderson DA, McArdle CS. Incidence of nausea and vomiting with cytotoxic chemotherapy. A prospective randomized trial of antiemetics. BMJ 1997; 1: 1323-5.
3. Tortorice PV, O'Connell MB. Management of chemotherapy-induced nausea and vomiting. Pharmacotherapy 1990; 10: 129-45.
4. Gralla RJ. Treating emesis. An overview of agents. P & T 1991; 16: 650-60.
5. Walton SC, Koenig TJ. Effectiveness and economy of low-dose ondansetron. Am J Health Syst Pharm 1995; 52: 546-7.
6. Cunningham D, Evans C, Gazet JC, et al. Comparison of antiemetic efficacy of domperidone, metoclopramide and dexamethasone in patients receiving outpatient chemotherapy regimens. BMJ 1987; 295: 250.
7. 3 receptors. Brit J Pharmacol 1988; 94: 397-412.
8. Hesketh PJ, Murphy WK, Lester EP, et al. GR38032F (GR-C507/75): A novel effective compound in the prevention of acute cisplatin induced emesis. J Clin Oncol 1989; 7: 700-5.
9. Andrews PLR. The pharmacologic profile of granisetron (Kytril). Semin Oncol 1994; 21: 3-9.
10. Chevallier B. Efficacy and safety of granisetron compared with high dose metoclopramide plus dexamethasone in patients receiving high dose cisplatin in a single blind study. Eur J Cancer 1990; 26: S33-36.
11. Chevallier B. The control of acute cisplatin induced emesis - A comparative study of granisetron and a combination regimen of high dose metoclopramide and dexamethasone. Br J Cancer 1993; 68: 176-80.
12. Park Y, Hatano Y, Sasamota S, Kato N, Okyama N, Yamazaki S. Antiemetic efficacy of granisetron in repeated CAF chemotherapy after breast cancer operation. Gan To Kayaku Ryoho 1997; 24: 573-7.
13. Silva RR, Bascioni R, Giorgi F, et al. Granisetron plus dexamethasone in moderately emetogenic chemotherapy: Evaluation of activity during three consecutive courses of chemotherapy support case. Cancer 1996; 4: 287-90.
14. Soukop M. A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. Eur J Cancer 1990; 26: S15-19.
15. Smith IE. A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. Eur J Cancer 1990; 26: S19-23.
16. Hacking A, The Granisetron Study Group: Oral granisetron-simple and effective: A preliminary report. Eur J Cancer 1992; 28: S28-32.
17. Bleiberg HH, Spielman M, Falkson G, et al. Antiemetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy: A dose-ranging study. Clin Ther 1995; 17: 38-51.
18. Ettinger D, Eisenberg P, Fitts D, et al. A double blind comparison of the efficacy of two dose regimens of oral granisetron (1 mg twice, 2 mg once) in preventing acute emesis in patients receiving moderately emetogenic chemotherapy. Cancer 1996; 78: 144-51.
19. The Italian Group for Antiemetic Research. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Eng J Med 1995; 332: 1-5.
20. Ozono S, Okajima E, Hirao TK, et al. A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP based combination chemotherapy induced emesis-outcomes of a multicenter randomized comparative study using the central registration method. Gan To Kagaku Ryoho 1997; 24: 349-56.
21. Hisano C, Nakano S, Okuma K, et al. Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer therapy. Gan To Kagaku Ryoho 1996; 23: 1175-81.
22. Sekine I, Nishiwaki Y, Kakinuma R, et al. A randomized crossover trial of granisetron and dexamethasone versus granisetron alone: the role of dexamethasone on day I in the control of cisplatin induced delayed emesis. Jpn J Clin Oncol 1996; 26: 164-8.
23. Heron JF, Goedhals L, Jordaan JP, et al. Oral graniseton alone and in combination with dexamethasone: A double blind randomized comparison against high-dose metoclopramide plus dexa-methasone in prevention of cisplatin-induced emesis. Ann Oncol 1994; 5: 579-84.
24. Ettinger DS. Preventing chemotherapy-induced nausea and vomiting: An update and a review of emesis. Semin Oncol 1995; 22: S6-18.
25. Pollera CF, Giannarelli D. Prognostic factors influencing cisplatin-induced emesis: Definition and validation of a predictive logistic modal. Cancer 1989; 64: 1117-22.
26. Sullivan JF, Leyden MJ, Bell R. Decreased cisplatin-induce nausea and vomiting with chronic alcohol ingestion. N Engl J med 1983; 309: 796.
27. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med 1993; 329: 1790-6.